1. NFATc1 regulates cell proliferation, migration, and invasion of ovarian cancer SKOV3 cells in vitro and in vivo
   Long Li et al, 2016 CrossRef
2. The ocular pharmacokinetics and biodistribution of phospho-sulindac (OXT-328) formulated in nanoparticles: Enhanced and targeted tissue drug delivery
   Ziyi Wen et al, 2018, International Journal of Pharmaceutics CrossRef
3. Targeting Key Stemness-Related Pathways in Human Cancers
   Krysta M. Coyle et al, 2015 CrossRef
4. High expression of NFAT2 contributes to carboplatin resistance in lung cancer
   Xi Liu et al, 2019, Experimental and Molecular Pathology CrossRef
5. NFAT as cancer target: Mission possible?
   Jiang-Jiang Qin et al, 2014, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
6. NFATC1 promotes cell growth and tumorigenesis in ovarian cancer up-regulating c-Myc through ERK1/2/p38 MAPK signal pathway
   Wenwen Xu et al, 2016, Tumor Biol. CrossRef
7. Inflammation-Related Pancreatic Carcinogenesis
   Juan-juan Dai et al, 2017, Pancreas CrossRef
8. Promising models for cancer-induced cachexia drug discovery
   Tsuyoshi Suzuki et al, 2020, Expert Opinion on Drug Discovery CrossRef
9. NFATc3 mediates the sensitivity of gastric cancer cells to arsenic sulfide
   Xiuli Zhang et al, 2017, Oncotarget CrossRef
10. Bufalin inhibits human diffuse large B-cell lymphoma tumorigenesis by inducing cell death through the Ca2+/NFATC1/cMYC pathway
    Jincheng Song et al, 2020 CrossRef
11. NSAIDs: Old Acquaintance in the Pipeline for Cancer Treatment and Prevention─Structural Modulation, Mechanisms of Action, and Bright Future
    Sandra Ramos-Inza et al, 2021, J. Med. Chem. CrossRef
12. RCAN1-mediated calcineurin inhibition as a target for cancer therapy
    Mengyi Lao et al, 2022, Mol Med CrossRef
13. The Antiangiogenic Effect and Ocular Pharmacology of Novel Modified Nonsteroidal Anti-Inflammatory Drugs in the Treatment of Oxygen-Induced Retinopathy
    Wei Huang et al, 2023, Journal of Ocular Pharmacology and Therapeutics CrossRef